Luye Pharma Group Ltd.

LYPHF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$1$1$1-$0
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0-$0
Stock-Based Comp.$0$0$0$0
Change in WC-$1$0$0-$0
Other Non-Cash-$0-$0-$0$0
Operating Cash Flow$0$2$2$0
Investing Activities
PP&E Inv.-$1-$1-$1-$2
Net Acquisitions-$1-$1$0-$1
Inv. Purchases-$2-$2-$3-$4
Inv. Sales/Matur.$4$3$3$2
Other Inv. Act.-$1-$0$0$1
Investing Cash Flow-$1-$1-$2-$3
Financing Activities
Debt Repay.$2-$0-$1-$0
Stock Issued$0$1$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$1$1
Financing Cash Flow$3$1$0$2
Forex Effect$0-$0-$0-$0
Net Chg. in Cash$2$1-$0-$1
Supplemental Information
Beg. Cash$3$2$2$4
End Cash$5$3$2$2
Free Cash Flow-$2$0$0-$1